Erguang Li

4.7k total citations
87 papers, 3.9k citations indexed

About

Erguang Li is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Erguang Li has authored 87 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Immunology and 17 papers in Epidemiology. Recurrent topics in Erguang Li's work include Virus-based gene therapy research (10 papers), Immune Response and Inflammation (9 papers) and Herpesvirus Infections and Treatments (8 papers). Erguang Li is often cited by papers focused on Virus-based gene therapy research (10 papers), Immune Response and Inflammation (9 papers) and Herpesvirus Infections and Treatments (8 papers). Erguang Li collaborates with scholars based in China, United States and Czechia. Erguang Li's co-authors include Glen R. Nemerow, Dwayne G. Stupack, David A. Cheresh, Stuart Kornfeld, Richard Klemke, Alice M. Clark, Charles D. Hufford, Renxiang Tan, Gary Bokoch and David D. Schlaepfer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Erguang Li

84 papers receiving 3.8k citations

Peers

Countries citing papers authored by Erguang Li

Since Specialization

Citations

This map shows the geographic impact of Erguang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erguang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erguang Li more than expected).

Fields of papers citing papers by Erguang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erguang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erguang Li. The network helps show where Erguang Li may publish in the future.

Co-authorship network of co-authors of Erguang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Erguang Li. A scholar is included among the top collaborators of Erguang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erguang Li. Erguang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Photo-generating Type-I ROS and aryl radicals by mitochondrial-targeting oxime-ester photogenerator for pyroptosis-mediated anti-hypoxia photoimmunotherapy 2025 ·Bioactive Materials ·Qimin Zhan, Yu‐Lin Kuang, (unknown), (unknown), (unknown), Jian Chen, Erguang Li, Junwei Wang, Shuoji Zhu, Huanlei Huang, Lei Wang, Ping Zhu, Ruiyuan Liu	0
2	Combined delivery of IL12 and an IL18 mutant without IL18BP-binding activity by an adenoviral vector enhances tumor specific immunity 2025 ·Scientific Reports ·(unknown), (unknown), Erguang Li	1
3	Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model 2024 ·Frontiers in Immunology ·(unknown), Yixuan Wang, (unknown), Anthony A. Fernald, Erguang Li, Alexander T. Pearson, Randy F. Sweis, Trachette L. Jackson	2
4	An engineered TNFR1-selective human lymphotoxin-alpha mutant delivered by an oncolytic adenovirus for tumor immunotherapy 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Yan Cheng, Yu Liu, (unknown), Dan Zhang, Yang Yang, Yuqing Miao, Susu He, (unknown), Erguang Li	2
5	Discovery of Potent and Oral Bioavailable MAT2A Inhibitors for the Treatment of MTAP-Deleted Tumors 2023 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Lifei Liu, Wen Jiang, (unknown), (unknown), Jun Yang, Erguang Li, (unknown)	4
6	LINE-1 repression in Epstein–Barr virus-associated gastric cancer through viral–host genome interaction 2023 ·Nucleic Acids Research ·Mengyu Zhang, (unknown), (unknown), (unknown), Lingling Wang, Jingping Yang, Erguang Li, Susu He	12
7	Pharmacological Potential of Betulin as a Multitarget Compound 2023 ·Biomolecules ·(unknown), (unknown), Erguang Li, Elena G. Kovaleva, Mikhail V. Tsurkan	46
8	Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma 2022 ·Nature Communications ·(unknown), Yang Zhang, (unknown), Yao Fu, Xiaozhi Zhao, Jing Zhang, Ke Zuo, (unknown), Song Jiang, Zhaohui Qin, Erguang Li, Hongqian Guo, Zhihong Liu, Jingping Yang	31
9	RSV Infection in Neonatal Mice Induces Pulmonary Eosinophilia Responsible for Asthmatic Reaction 2022 ·Frontiers in Immunology ·Dan Zhang, Jie Yang, Yuanhui Zhao, Jinjun Shan, Lingling Wang, Guang Yang, Susu He, Erguang Li	14
10	An experimental study of the anti-dysmenorrhea effect of Chinese herbal medicines used in Jin Gui Yao Lue 2019 ·Journal of Ethnopharmacology ·Meng Li, (unknown), (unknown), Weiran Zheng, Zhenzhong Wang, Wei Xiao, Yang Sun, Erguang Li	13
11	Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice 2016 ·Scientific Reports ·Hengfei Shi, Ke Ren, (unknown), Wei Zhang, (unknown), Ren Xiang Tan, Erguang Li	72
12	A Novel Benzenediamine Derivate Rescued Mice from Experimental Sepsis by Attenuating Proinflammatory Mediators via IRAK4 2014 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), Yuxian Song, Xianqin Liu, Liu Yang, Nan Jiang, Chen Dai, Erguang Li, Renxiang Tan, Yayi Hou	42
13	A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling 2014 ·Cancer Biology & Therapy ·Yuxian Song, Huan Dou, Ping Wang, Shuli Zhao, Tingting Wang, (unknown), Junli Zhao, Erguang Li, Renxiang Tan, Yayi Hou	22
14	Apigenin Inhibits Enterovirus-71 Infection by Disrupting Viral RNA Association with trans-Acting Factors 2014 ·PLoS ONE ·Wei Zhang, (unknown), (unknown), Jingjing Wang, Xiaohong Chen, Yayi Hou, Renxiang Tan, Erguang Li	98
15	Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction 2012 ·Journal of Molecular and Cellular Cardiology ·Jun Xie, Jingjing Wang, (unknown), Qin Dai, Yonghong Yong, (unknown), (unknown), Erguang Li, Albert Ferro, Biao Xu	36
16	Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation 2011 ·Antiviral Research ·Xiaohong Chen, Zhong‐Xia Wang, Ziying Yang, Jingjing Wang, (unknown), Renxiang Tan, Erguang Li	89
17	A Variant of TNFR2-Fc Fusion Protein Exhibits Improved Efficacy in Treating Experimental Rheumatoid Arthritis 2010 ·PLoS Computational Biology ·Tong Yang, Zheng Wang, Fang Wu, (unknown), (unknown), Erguang Li, (unknown), (unknown), Gang Li, Jinsong Wu, Luochun Wang, Haibo Wang, Yanjun Liu	14
18	Production of Functional Antibodies Generated in a Nonlytic Insect Cell Expression System 2001 ·Protein Expression and Purification ·Erguang Li, S Brown, Carrie S. Dolman, (unknown), Glen R. Nemerow	17
19	Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery 2000 ·Gene Therapy ·Erguang Li, S Brown, Dan J. Von Seggern, (unknown), Glen R. Nemerow	20
20	T cell responses in calcineurin A alpha-deficient mice. 1996 ·The Journal of Experimental Medicine ·(unknown), (unknown), Jue Chen, Daniel Ladd, Erguang Li, Frederick W. Alt, Greg Wiederrecht, John G. Cryan, Edward A. O’Neill, Christine E. Seidman, Abul K. Abbas, J G Seidman	129

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact